Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal
- PMID: 1723740
Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal
Abstract
The unknowns persisting in the understanding of the mode of action of anti-core lipopolysaccharide antibodies are discussed, and a study of two anti-lipid A monoclonal antibodies is reviewed. This article also critically analyzes the results of the recent clinical trials with monoclonal antibodies.
Similar articles
-
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.Prog Clin Biol Res. 1991;367:141-59. Prog Clin Biol Res. 1991. PMID: 1924424 Review.
-
Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.Crit Care Med. 1993 Feb;21(2 Suppl):S32-9. doi: 10.1097/00003246-199302001-00007. Crit Care Med. 1993. PMID: 8428494 Review.
-
Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis.Hum Antibodies Hybridomas. 1993 Jan;4(1):36-9. Hum Antibodies Hybridomas. 1993. PMID: 8431557 Clinical Trial.
-
The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.Infect Dis Clin North Am. 1991 Dec;5(4):899-913. Infect Dis Clin North Am. 1991. PMID: 1783775 Review.
-
Production, characterization and biological effects of monoclonal antibodies to different parts of the gram-negative lipopolysaccharide core region.Prog Clin Biol Res. 1988;272:373-82. Prog Clin Biol Res. 1988. PMID: 2455918 No abstract available.
Cited by
-
[Endotoxins. Pathogenetic meaning of sepsis].Anaesthesist. 2003 Dec;52 Suppl 1:S7-S13. doi: 10.1007/s00101-003-0587-7. Anaesthesist. 2003. PMID: 14727044 Review. German. No abstract available.
-
Endotoxemia: methods of detection and clinical correlates.Clin Microbiol Rev. 1995 Apr;8(2):268-92. doi: 10.1128/CMR.8.2.268. Clin Microbiol Rev. 1995. PMID: 7621402 Free PMC article. Review.
-
An artificial glycoconjugate containing the bisphosphorylated glucosamine disaccharide backbone of lipid A binds lipid A monoclonal antibodies.Infect Immun. 1993 Oct;61(10):4514-7. doi: 10.1128/iai.61.10.4514-4517.1993. Infect Immun. 1993. PMID: 8406846 Free PMC article.
-
The economic impact of HA-1A (Centoxin) against endotoxin.Pharmacoeconomics. 1992 Nov;2(5):408-13. doi: 10.2165/00019053-199202050-00008. Pharmacoeconomics. 1992. PMID: 10147053
-
Fc gamma receptor-dependent clearance is enhanced following lipopolysaccharide in vivo treatment.Immunology. 1997 Dec;92(4):536-43. doi: 10.1046/j.1365-2567.1997.00376.x. Immunology. 1997. PMID: 9497496 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources